pyrrolidine dithiocarbamate has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amarnath, K; Amarnath, V; Valentine, HL; Valentine, WM | 1 |
| Does, MD; Marshall, V; Tonkin, EG; Valentine, HL; Valentine, WM | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Demyelinating Diseases
| Article | Year |
|---|---|
Dietary copper enhances the peripheral myelinopathy produced by oral pyrrolidine dithiocarbamate.
Topics: Administration, Oral; Animals; Chromatography, Liquid; Copper; Demyelinating Diseases; Diet; Dose-Response Relationship, Drug; Drug Synergism; Environmental Pollutants; Globins; Male; Mass Spectrometry; Microscopy, Electron; Peripheral Nerves; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Thiocarbamates; Tissue Distribution | 2006 |
Multicomponent T2 analysis of dithiocarbamate-mediated peripheral nerve demyelination.
Topics: Animals; Coloring Agents; Copper; Demyelinating Diseases; Injections, Intraperitoneal; Magnetic Resonance Imaging; Male; Peripheral Nerves; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spectrophotometry, Atomic; Thiocarbamates; Tolonium Chloride | 2007 |